Intensive and Critical Care Nursing
Volume 24, Issue 1 , Pages 59-62 , February 2008

Rasburicase in the prevention and treatment of tumour lysis syndrome

  • Nicola Mayne

      Affiliations

    • Paediatric and Adolescent Services, University College London Hospitals NHS Foundation Trust, London, UK
    • Corresponding Author InformationCorresponding author.
    • ,
  • Simon Keady

      Affiliations

    • Women and Children's Services, University College London Hospitals NHS Foundation Trust, London, UK
    • ,
  • Meera Thacker

      Affiliations

    • Critical Care Services, Royal Free Hampstead NHS Trust, UK

,Accepted 23 May 2007.

References 

  1. Mahmoud HH, Leverger G, Patte C, et al. Advances in the management of malignancy-associated hyperuricaemia. Br J Cancer. 1998;77(4):18–20
  2. Patte C, Sakiroglu C, Ansoborlo S, et al. Urate-oxidase in the prevention and treatment pf metabolic complications in patients with B-cell lymphoma and leukaemia, treated in the Societe Francais d’Oncologie Pediatrique LMB89 protocol. Ann Oncol. 2002;13:789–795
  3. Pui CH, Mahmoud HH, Wley JM, et al. Recombinant urate oxidase for the prophylaxis or treatment of hyperuricaemia in patients with leukaemia or lymphoma. J Clin Oncol. 2001;19(3):697–704
  4. Coiffier B, Mounier N, Bologna S, et al. Efficacy and safety of rasburicase (recombinant urate oxidase) for the prevention and treatment of hyperuricaemia during induction chemotherapy of aggressive non-Hodgkin's lymphoma: results of the GRAAL1 (Groupe d’Etude des Lymphomes de l’Adulte Trial on rasburicase activity in adult lymphoma) study. J Clin Oncol. 2003;21(23):4402–4406
  5. Goldman SC, Holcenberg JS, Finkletstein JZ, et al. A randomised comparison between rasburicase and allopurinol in children with lymphoma or leukaemia at high risk for tumour lysis. Blood. 2001;97(10):2998–3003
  6. Bosly A, Sonet A, Ross Pinkerton C, et al. Rasburicase (recombinant urate oxidase) for the management of hyperuricaemia in patients with cancer. Report of an international compassionate use study. Cancer. 2003;98(5):1048–1054

PII: S0964-3397(07)00055-9

doi: 10.1016/j.iccn.2007.06.002

Intensive and Critical Care Nursing
Volume 24, Issue 1 , Pages 59-62 , February 2008

Article Tools

* Image Usage & Resolution